Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today statistically significant and clinically meaningful results from the Phase III ALLEGORY study of Gazyva® ...

Third quarter 2025 total revenue of $161.7 million, including BRIUMVI U.S. net revenue of $152.9 millionRaises full year 2025 global revenue ...

NUTLEY, N.J., Nov. 3, 2025 /PRNewswire/ -- Eisai announced today the presentation of clinical research in gynecologic oncology during the International Gynecologic Cancer Society (IGCS) 2025 Annual ...

Older adults who have a heart attack may be more likely to develop epilepsy later in life, according to a study published in ...

AVEO Oncology, an LG Chem company (AVEO), and HiberCell, Inc. (HiberCell) announced today that the companies have entered ...

Microscopic fibers in tissue are critical for our understanding of disease, but they have been difficult to study.

In patients with elevated baseline amyloid, there was an association between higher physical activity and slower cognitive/functional decline.

The signs were there but subtle. Dustin Chandler never did his homework. He was labeled lazy at school. It wasn’t until years later when his mother, now working at a pediatric clinic, watched him ...

First-in-Human Phase 1 data for allogeneic CAR-T cell therapy for NHL to be featured in oral session ...

Gilead Sciences, Inc. and Kite, a Gilead Company, will present 21 abstracts, including 5 oral presentations, during the 67th American Society of Hematology (ASH) Annual Meeting and Exposition ...